Seeking Alpha

Sanofi-Aventis (SNY)

()

Analysis
Articles4 new
Instablogs1 new
StockTalks2 new
Sentiment
Comments13 new

News & PR
Market Currents

Buzz
Twitter: SNY

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Equities Update: Broad Market Gains

Dec 21 • Midnight Trader • 1 Comment
Sanofi-Aventis Acquires Chattem in $1.9 Billion Cash Deal

Dec 21 • optionMONSTER • Comment!
Sanofi-Aventis Going OTC with Chattem Buy

Dec 21 • EP Vantage • 3 Comments
Wall Street Breakfast: Must-Know News

Dec 21 • SA Editor Eli Hoffmann • 9 Comments
This Week's Failed Trials, Missed Targets in Biotech

Dec 20 • The Burrill Report • 1 Comment
China Biotech Week in Review: Deals and CRO News

Dec 14 • ChinaBio Today • 1 Comment
Making and Breaking Biotech Deals

Dec 14 • The Burrill Report • Comment!
H1N1: What It Means for Pharma

Dec 2 • R. Scott Raynovich • 2 Comments
Immunogen's Busy Month, Part II

Dec 2 • Ohad Hammer • Comment!
Immunogen's Busy Month, Part I

Dec 1 • Ohad Hammer • Comment!
Health Care Takes Bigger Slice of Risk Capital

Nov 30 • Sydney Williams • Comment!
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
Sanofi Expands Regeneron Agreement

Nov 26 • Zacks.com • Comment!
Competition in Blood - Thinners: Win - Win for Everyone Involved

Nov 20 • Derek Lowe • Comment!
AOB's Cash Generation Provides Backstop to Earnings Miss

Nov 17 • Jeffrey Walkenhorst • 3 Comments
Analyze Earnings Yield Like Warren Buffett

Nov 17 • YCHARTS.com • 1 Comment
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity'

Nov 15 • The Burrill Report • Comment!
Big Pharma Willing to Pay for Biotech Innovation

Nov 15 • The Burrill Report • Comment!
The Complete List of French ADR Stocks

Nov 9 • David Hunkar • 2 Comments
D.C. Vaccine Conference: Why Investors Should Stay Tuned

Nov 9 • M. E. Garza • Comment!
EFA: Diversify Your Portfolio Outside the U.S.

Nov 8 • Hao Jin • 4 Comments
A 130 / 30 Global Pharma Strategy

Nov 5 • Mike Havrilla • 2 Comments
China Biotech Week in Review: Is CRO Consolidation a New Theme?

Nov 1 • ChinaBio Today • 1 Comment
This Week in Biotech: More Treats than Tricks

Nov 1 • The Burrill Report • Comment!
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
Unilife: Medical Device Innovator Creating Jobs in Pennsylvania

Oct 30 • Mike Havrilla • 2 Comments
Stock Screener: 10 Foreign Stocks with Caps Above $100B, Yields Above 3%

Oct 29 • David Hunkar • Comment!
Sanofi-Aventis's New JV Will Provide Entry into China’s OTC Market

Oct 27 • ChinaBio Today • Comment!
Wall Street Breakfast: Must-Know News

Oct 23 • SA Editor Eli Hoffmann • 19 Comments
Tough Decisions for Antigenics

Oct 22 • EP Vantage • 3 Comments
China Biotech Week in Review: A Multitude of Deals and Collaborations

Oct 18 • ChinaBio Today • 1 Comment
Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • 1 Comment
Dow 10k: The Higher They Rise, The Harder They Fall

Oct 15 • Matthew Rafat • 20 Comments
Sanofi-Aventis Animal Health Division Starts China Facility Expansion

Oct 13 • ChinaBio Today • Comment!
OncoGenex: Room for Further Growth?

Oct 8 • EP Vantage • Comment!
H1N1: How to Buy into the Fear

Oct 7 • Jim Van Meerten • 1 Comment
Sanofi-Aventis Boosts Pipeline with In-Licensing Deals, Acqusitions

Oct 6 • Zacks.com • Comment!
Capital Markets Open Up to Biotechs

Oct 4 • The Burrill Report • Comment!
Healthcare Takeover Talk Continues

Sep 30 • M. E. Garza • 8 Comments
Analyzing the Oracle: Berkshire Hathaway Holdings and Analysis

Sep 29 • Value Expectations • 2 Comments
Glaxo Could Find Reasons to Extend Its Alliance with Dr. Reddy's

Sep 22 • EP Vantage • 2 Comments

Sanofi-Aventis (SNY)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers